Physician profile
Amy E Vaughan
NPI 1700068723
$1,826.59
in general payments reported to CMS, 2019-2025
23 companies · $356 in 2025
The $356 reported for 2025 was more than what a typical Obstetrics & Gynecology provider received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $125 · 2020: $42.63 · 2021: $391 · 2022: $473 · 2023: $285 · 2024: $154 · 2025: $356.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $795.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $795.10 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $400.29 | 2020-2022 | |
| Exeltis, USA INC. | $229.29 | 2022-2025 | Slynd |
| Allergan, INC. | $188.00 | 2022 | |
| Organon LLC | $127.18 | 2021-2024 | Nexplanon |
| Clovis Oncology, INC. | $125.00 | 2019 | |
| Astellas Pharma US INC | $106.45 | 2023-2025 | Veozah |
| Pfizer INC. | $81.65 | 2021-2025 | |
| Medtronic, INC. | $77.84 | 2025 | Truclear |
| Mayne Pharma Commercial LLC | $71.84 | 2023-2025 | |
| Millicent US INC | $64.33 | 2023-2025 | Intrarosa, Femring, Femlyv |
| Aspira Women'S Health INC | $47.27 | 2022 | |
| Ethicon US, LLC | $42.87 | 2025 | Dermabond Prineo, Stratafix |
| Gynesonics, INC. | $40.97 | 2021 | |
| Merck Sharp & Dohme LLC | $37.61 | 2020-2021 | |
| Bayer Healthcare Pharmaceuticals INC. | $34.88 | 2022-2025 |
Show all 23 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Mylan Pharmaceuticals INC. | $26.90 | 2021 | |
| Dilon Technologies, INC. | $21.36 | 2024 | Hemoblast Bellows |
| Convatec INC. | $21.27 | 2023 | |
| Shield Therapeutics INC | $18.99 | 2023 | Accrufer |
| Hologic Sales and Service, LLC | $17.73 | 2025 | Fluent Fluid Management System |
| Evofem Biosciences, INC. | $16.45 | 2025 | Phexxi, Solosec, Phexx |
| Renovia INC | $15.23 | 2021 | |
| Asensus Surgical, INC. | $13.19 | 2023 | Senhance |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Amy Vaughan listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.